BERLIN -- Combining enzalutamide (Xtandi) with androgen deprivation therapy (ADT) significantly improved overall survival (OS ...

Gilead Sciences' Trodelvy lowered the risk of disease progression in an aggressive type of breast cancer by 38% when used as ...

Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death ...

Fox News medical contributor Dr. Nicole Saphier discusses former ‘Bachelorette’ star Katie Thurston promoting breast cancer awareness, how to lower the risk and Amazon’s telehealth model on ‘Fox & ...

Hyderabad oncologist explains the link between stress and cancer, separating myths from facts and sharing how chronic stress can affect your body and health.

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

BERLIN -- The antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) delivered impressive results in different ...

New research reveals why colon cancer is surging in people under 50—and it's not genetics. Scientists point to one dietary ...

Ibuprofen is a household name—the go-to remedy for everything from headaches to period pain. But recent research suggests ...

Pfizer and Astellas' Padcev, with Merck's Keytruda, reduces tumor risk in bladder cancer patients, showing promising results.

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Retail buzz around Summit Therapeutics picked up Sunday after the biotech reported what it called a first-of-its-kind result ...